14.08
-0.11
(-0.78%)
At close: 4:00:00 PM EDT
13.91
-0.17
(-1.22%)
After hours: 6:12:18 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
139,927
139,927
89,077
49,005
22,593
Cost of Revenue
40,984
40,984
35,312
27,677
18,076
Gross Profit
98,943
98,943
53,765
21,328
4,517
Operating Expense
135,801
135,801
103,850
84,646
57,304
Operating Income
-36,858
-36,858
-50,085
-63,318
-52,787
Net Non Operating Interest Income Expense
9,453
9,453
3,266
-3,429
-3,628
Other Income Expense
--
--
-1,769
--
7,735
Pretax Income
-27,405
-27,405
-48,588
-66,747
-48,680
Tax Provision
50
50
20
9
8
Net Income Common Stockholders
-27,455
-27,455
-48,608
-66,756
-48,688
Diluted NI Available to Com Stockholders
-27,455
-27,455
-48,608
-66,756
-48,688
Basic EPS
-0.71
--
-1.41
-2.41
-3.57
Diluted EPS
-0.71
--
-1.41
-2.41
-3.57
Basic Average Shares
38,867.73
--
34,455.11
27,661.98
13,625.04
Diluted Average Shares
38,867.73
--
34,455.11
27,661.98
13,625.04
Total Operating Income as Reported
-36,858
-36,858
-50,085
-63,318
-52,787
Total Expenses
176,785
176,785
139,162
112,323
75,380
Net Income from Continuing & Discontinued Operation
-27,455
-27,455
-48,608
-66,756
-48,688
Normalized Income
-27,455
-27,455
-46,839
-66,756
-56,423
Interest Income
9,474
9,474
6,574
1,517
54
Interest Expense
21
21
3,308
4,946
3,682
Net Interest Income
9,453
9,453
3,266
-3,429
-3,628
EBIT
-27,384
-27,384
-45,280
-61,801
-44,998
EBITDA
-23,760
-23,760
-41,037
-57,779
-41,010
Reconciled Cost of Revenue
40,984
40,984
35,312
27,677
18,076
Reconciled Depreciation
3,624
3,624
4,243
4,022
3,988
Net Income from Continuing Operation Net Minority Interest
-27,455
-27,455
-48,608
-66,756
-48,688
Total Unusual Items Excluding Goodwill
--
--
-1,769
--
7,735
Total Unusual Items
--
--
-1,769
--
7,735
Normalized EBITDA
-23,760
-23,760
-39,268
-57,779
-48,745
Tax Rate for Calcs
0
0
--
--
--
12/31/2021 - 7/30/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CVRX CVRx, Inc.
6.23
-3.86%
GKOS Glaukos Corporation
90.07
+0.46%
SGHT Sight Sciences, Inc.
2.3800
+5.31%
PRCT PROCEPT BioRobotics Corporation
52.07
+2.64%
TMCI Treace Medical Concepts, Inc.
6.74
-3.65%
CBLL CeriBell, Inc.
15.00
+34.53%
TMDX TransMedics Group, Inc.
80.58
+5.51%
TELA TELA Bio, Inc.
0.9790
+4.15%
OM Outset Medical, Inc.
10.16
+5.83%
ESTA Establishment Labs Holdings Inc.
30.34
+0.66%